Garnero P - Search Results

1

Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone.

Garnero P, Thompson E, Woodworth T, Smolen JS. Garnero P, et al. Arthritis Rheum. 2010 Jan;62(1):33-43. doi: 10.1002/art.25053. Arthritis Rheum. 2010. PMID: 20039425 Clinical Trial.

2

Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women.

Garnero P, Borel O, Sornay-Rendu E, Delmas PD. Garnero P, et al. J Bone Miner Res. 1995 Sep;10(9):1283-8. doi: 10.1002/jbmr.5650100902. J Bone Miner Res. 1995. PMID: 7502697

3

Decreased bone turnover in oral contraceptive users.

Garnero P, Sornay-Rendu E, Delmas PD. Garnero P, et al. Bone. 1995 May;16(5):499-503. doi: 10.1016/8756-3282(95)00075-o. Bone. 1995. PMID: 7654464

4

Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.

Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Garnero P, et al. J Clin Endocrinol Metab. 1994 Dec;79(6):1693-700. doi: 10.1210/jcem.79.6.7989477. J Clin Endocrinol Metab. 1994. PMID: 7989477 Clinical Trial.

5

Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.

Garnero P, Gineyts E, Riou JP, Delmas PD. Garnero P, et al. J Clin Endocrinol Metab. 1994 Sep;79(3):780-5. doi: 10.1210/jcem.79.3.8077361. J Clin Endocrinol Metab. 1994. PMID: 8077361

6

Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro.

Garnero P, Grimaux M, Seguin P, Delmas PD. Garnero P, et al. J Bone Miner Res. 1994 Feb;9(2):255-64. doi: 10.1002/jbmr.5650090215. J Bone Miner Res. 1994. PMID: 8140939

7

Markers of bone turnover in hyperthyroidism and the effects of treatment.

Garnero P, Vassy V, Bertholin A, Riou JP, Delmas PD. Garnero P, et al. J Clin Endocrinol Metab. 1994 Apr;78(4):955-9. doi: 10.1210/jcem.78.4.8157727. J Clin Endocrinol Metab. 1994. PMID: 8157727

8

Genetic influence on bone turnover in postmenopausal twins.

Garnero P, Arden NK, Griffiths G, Delmas PD, Spector TD. Garnero P, et al. J Clin Endocrinol Metab. 1996 Jan;81(1):140-6. doi: 10.1210/jcem.81.1.8550741. J Clin Endocrinol Metab. 1996. PMID: 8550741

9

Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: the OFELY Study.

Garnero P, Borel O, Sornay-Rendu E, Arlot ME, Delmas PD. Garnero P, et al. J Bone Miner Res. 1996 Jun;11(6):827-34. doi: 10.1002/jbmr.5650110614. J Bone Miner Res. 1996. PMID: 8725180

10

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.

Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Garnero P, et al. J Bone Miner Res. 1996 Mar;11(3):337-49. doi: 10.1002/jbmr.5650110307. J Bone Miner Res. 1996. PMID: 8852944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results